Bio-absorbable Collagen Wound Dressing with Biguanide

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Collagen-based wound dressings face issues with rapid absorption in well-blood-supplied tissues, leading to incomplete healing and increased infection risk due to frequent bandage changes, and existing silver-containing dressings have limitations in efficacy and stability.

Innovation Solution

A bio-absorbable collagen-based wound dressing incorporating a linear polymer biguanide, such as polyhexamethylene biguanide, which slows down collagen absorption and provides antimicrobial properties to prevent infection and promote healing, combined with a tenside to reduce biofilm formation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If collagen is used as a wound dressing material, then good body toleration and absorbability are achieved, but overly rapid absorption occurs in well-blood-supplied tissue within 2-3 days

Engineering Contradiction:
Improvebody tolerationVSAvoidabsorption time
Core Design Contradiction:
ReliabilityVSDuration of action of stationary object

Solution Approach 1:

The patent combines collagen with a depository substance (antibiotic, antifungal, or antiviral agent) to create a composite wound dressing. The collagen provides good body toleration and biocompatibility, while the depository substance slows down the overall absorption and degradation process, extending the dressing's effective duration from 2-3 days to at least 72 hours or longer in well-blood-supplied tissue.

Inventive Principle:
Principle #40Composite materials

2Productivity

If collagen absorption is accelerated for quick healing, then absorbability is improved, but infection risk increases due to frequent bandage changes

Engineering Contradiction:
Improvehealing speedVSAvoidinfection risk
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent incorporates depository substances (antibiotics, antifungals, or antivirals) into the collagen dressing before application. These substances are released over time to prevent infections proactively, reducing the need for frequent bandage changes and thereby lowering the risk of infection from repeated wound exposure during changes.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

By creating a composite of collagen with depository substances, the dressing maintains extended presence in the wound (at least 72 hours) while providing continuous antimicrobial protection, thus reducing frequent changes and associated infection risks without compromising healing speed.

Inventive Principle:
Principle #40Composite materials

3Object-affected harmful factors

If silver compounds are used for antimicrobial protection, then bacteriostatic and fungistatic properties are achieved, but problems occur in use with efficacy and stability limitations

Engineering Contradiction:
Improvemicrobial protectionVSAvoidefficacy stability
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent transitions from using silver compounds to employing depository substances (antibiotics, antifungals, or antivirals) that provide more stable and reliable antimicrobial, antifungal, or antiviral protection. This parameter change in the type of active substance improves efficacy stability while maintaining microbe protection capabilities.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The dressing maintains effectiveness for at least 72 hours without complete absorption, reducing infection risk and accelerating wound healing by preventing microbial spread and biofilm formation, while being non-cytotoxic and compatible with wound tissue.

Implementation Method 1

Overly rapid absorption of collagen in the body... depends on its structure and especially the degree of cross-linking but, on the other hand, is decisively influenced by the application site

Methodology Applied
Scientific EffectAbsorption (physical): Absorption (physical)

Implementation Method 2

linear polymer biguanide and/or a water-soluble salt thereof... provides antimicrobial properties to prevent infection and promote healing

Methodology Applied
Scientific EffectAntimicrobial action:

Implementation Method 3

combined with a tenside to reduce biofilm formation

Methodology Applied
Scientific EffectSurfactant action: Surfactant

Implementation Method 4

the collagen interacts with structures of the vascular wall and the connective tissue proteins and activates body cells which are involved in wound healing, especially the fibroblasts

Methodology Applied
Scientific EffectCell activation:

Implementation Method 5

the collagen is absorbed by the body by immigrated macrophages and collagenase

Methodology Applied
Scientific EffectEnzymatic degradation: Enzyme

Implementation Method 6

the collagen is absorbed by the body by immigrated macrophages and collagenase

Methodology Applied
Scientific EffectPhagocytosis:

Data Source

PatentUS7604816B2Bio-absorbable collagen-based wound dressing
Publication Date: 2009.10.20 RESORBA MEDICAL GMBH

AI summary

A collagen-based bio-absorbable wound dressing which contains a linear polymer biguanide and/or a water-soluble salt thereof. The biguanide is preferably polyhexamethylene biguanide. The bio-absorbable wound dressing has a long residence time in the body, is extremely well tolerated and leads to rapid and uncomplicated wound healing with clearly reduced infection risk.